Growth Metrics

Omeros (OMER) EBT (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 239.84%
Dec 31, 2025 -195.39%
Sep 30, 2025 60.10%
Jun 30, 2025 17.14%
Mar 31, 2025 -9.66%
Dec 31, 2024 7.70%
Sep 30, 2024 43.01%
Jun 30, 2024 -48.52%
Mar 31, 2024 -1.04%
Dec 31, 2023 15.98%
Sep 30, 2023 -16.62%
Jun 30, 2023 -11.62%
Mar 31, 2023 13.82%
Dec 31, 2022 15.96%
Sep 30, 2022 -31.41%
Jun 30, 2022 -5.57%
Mar 31, 2022 62.44%
Dec 31, 2021 -363.20%
Sep 30, 2021 55.06%
Jun 30, 2021 -0.66%
Mar 31, 2021 42.80%
Dec 31, 2020 -89.45%
Sep 30, 2020 -37.61%
Jun 30, 2020 -13.79%
Mar 31, 2020 73.56%
Dec 31, 2019 -579.59%
Sep 30, 2019 -10.73%
Jun 30, 2019 40.14%
Mar 31, 2019 -5.15%
Dec 31, 2018 41.01%
Sep 30, 2018 -16.77%
Jun 30, 2018 -12.38%
Mar 31, 2018 -79.65%
Dec 31, 2017 -115.27%
Sep 30, 2017 46.19%
Jun 30, 2017 4.72%
Mar 31, 2017 -7.54%
Dec 31, 2016 -0.96%
Sep 30, 2016 -10.85%
Jun 30, 2016 38.61%
Mar 31, 2016 -10.50%
Dec 31, 2015 6.56%
Sep 30, 2015 -19.33%
Jun 30, 2015 10.50%
Mar 31, 2015 10.47%
Dec 31, 2014 -16.72%
Sep 30, 2014 0.43%
Jun 30, 2014 -10.99%
Mar 31, 2014 -17.45%
Dec 31, 2013 0.71%
Sep 30, 2013 -2.01%
Jun 30, 2013 -29.68%
Mar 31, 2013 -34.29%
Dec 31, 2012 41.24%
Sep 30, 2012 -54.59%
Jun 30, 2012 -1.60%
Mar 31, 2012 17.53%
Dec 31, 2011 -55.20%
Sep 30, 2011 -22.35%
Jun 30, 2011 18.79%
Mar 31, 2011 23.98%
Dec 31, 2010 -14.26%
Sep 30, 2010 3.47%